These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 26658360)
1. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. Bansal R; van Baarlen J; Storm G; Prakash J Sci Rep; 2015 Dec; 5():18272. PubMed ID: 26658360 [TBL] [Abstract][Full Text] [Related]
8. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109 [TBL] [Abstract][Full Text] [Related]
9. P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells. Jiang M; Cui BW; Wu YL; Zhang Y; Shang Y; Liu J; Yang HX; Qiao CY; Zhan ZY; Ye H; Jin Q; Nan JX; Lian LH Toxicol Lett; 2020 Oct; 333():22-32. PubMed ID: 32721574 [TBL] [Abstract][Full Text] [Related]
10. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Wang YC; He F; Feng F; Liu XW; Dong GY; Qin HY; Hu XB; Zheng MH; Liang L; Feng L; Liang YM; Han H Cancer Res; 2010 Jun; 70(12):4840-9. PubMed ID: 20501839 [TBL] [Abstract][Full Text] [Related]
14. Novel Insights on Notch signaling pathways in liver fibrosis. Ni MM; Wang YR; Wu WW; Xia CC; Zhang YH; Xu J; Xu T; Li J Eur J Pharmacol; 2018 May; 826():66-74. PubMed ID: 29501868 [TBL] [Abstract][Full Text] [Related]
15. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754 [TBL] [Abstract][Full Text] [Related]
16. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. Zhang K; Han X; Zhang Z; Zheng L; Hu Z; Yao Q; Cui H; Shu G; Si M; Li C; Shi Z; Chen T; Han Y; Chang Y; Yao Z; Han T; Hong W Nat Commun; 2017 Jul; 8(1):144. PubMed ID: 28747678 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800 [TBL] [Abstract][Full Text] [Related]
18. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells. Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033 [TBL] [Abstract][Full Text] [Related]